Local activation of the killing mechanism in PU5 antibody-dependent cell-mediated cytotoxicity effector cells
- PMID: 6600483
Local activation of the killing mechanism in PU5 antibody-dependent cell-mediated cytotoxicity effector cells
Abstract
This study was undertaken to determine whether ADCC effector cells expressed their killing mechanism globally throughout the entire cell surface or locally in a restricted area. Nonantibody-coated erythrocytes were bound to PU5 ADCC effector cells by either Con A or protein A-Ig bridges, and the effector cells with the adherent nonspecific erythrocyte target cells were mixed with specific antibody-coated erythrocytes. Our results indicated that the Con A or protein A-Ig-linked erythrocytes were not destroyed while the effector cell was in the process of killing specific antibody-coated erythrocytes. Therefore, the ADCC killing mechanisms of PU5 cells require activation by the interaction of Fc receptor with specific antibody-coated erythrocytes, and these killing mechanisms, once activated, are expressed in a locally restricted area of the effector cells rather than globally throughout the entire surfaces of the ADCC effector cell. Previously, we investigated the expression of the killing mechanism in cytolytic T lymphocytes (CTL) and found that alloimmune CTL in the process of killing specific target cells did not kill nonspecific targets linked to the CTL by either wheat germ agglutinin or immunoglobulin bridges. Thus, with respect to the surface membrane expression of lytic activity, CTL and the PU5 ADCC effector cells are similar. Our findings support the view that the various effector killing cells have a common cytolytic pathway and differ only by the recognition and triggering mechanisms.
Similar articles
-
Alloimmune cytolytic T lymphocyte activity: triggering and expression of killing mechanisms in cytolytic T lymphocytes.J Immunol. 1981 Feb;126(2):513-6. J Immunol. 1981. PMID: 6969752
-
Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.J Immunol. 1984 Feb;132(2):594-8. J Immunol. 1984. PMID: 6606675
-
Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.J Immunol. 1982 Mar;128(3):1246-51. J Immunol. 1982. PMID: 6976989
-
Cell-mediated killing: effector mechanisms and mediators.Cancer Cells. 1990 May;2(5):138-45. Cancer Cells. 1990. PMID: 2201340 Review.
-
Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.Crit Rev Immunol. 1981 Jan;1(3):165-209. Crit Rev Immunol. 1981. PMID: 6174273 Review.
Cited by
-
Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development.Sci Rep. 2020 Feb 17;10(1):2778. doi: 10.1038/s41598-020-59368-7. Sci Rep. 2020. PMID: 32066753 Free PMC article.
-
Halothane anaesthesia and liver damage.Br Med J (Clin Res Ed). 1984 Oct 27;289(6452):1136-9. doi: 10.1136/bmj.289.6452.1136. Br Med J (Clin Res Ed). 1984. PMID: 6435802 Free PMC article. Review. No abstract available.